This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Companion Diagnostics Market

Activities by Major Players to Foster Companion Diagnostics Market Penetration: Key Highlights by FMI

Companion Diagnostics Market by Application, Technology & Region - Forecast 2022 - 2032

Companion Diagnostics Market Outlook (2022-2032)

[333 Pages Report] The global companion diagnostics market is predicted to garner a revenue of about US$ 5152.064939 million by 2032, up from US$ 2452.653722 million in 2022 with a CAGR of 7.1% during the forecast period.

Companion diagnostics is utilized to ascertain who would benefit from treatment and the demand for the same is on the surge as it comes in handy to identify if someone cannot be cured, but also conversely can be harmed by use of specific drug used for their ailment. Moreover, the companion diagnostics market growth is propelled by technological advancements which have brought a lot of changes in the method of disease treatment on the whole.

Companion diagnostics is characterized by growing requirement for enhanced personalized patient treatment that gives healthcare providers and their patients an assurance about the treatment result in a positive way, contrary to traditional treatment procedure, positively impacting the companion diagnostics market outlook.

Report Attribute

Details

Companion Diagnostics Market Value (2022)

US$ 2452.653722 Million

Companion Diagnostics Market Anticipated Forecast Value (2032)

US$ 5152.064939 Million

Companion Diagnostics Market Projected Growth Rate (2022-2032)

7.1%

The rise in tailored medicine usage in tandem with rising demand for targeted therapies contribute to the creation of customized CDx and the expansion of the worldwide companion diagnostics market size.

Additionally, the advantages of CDx tests, such as their high sensitivity, affordability, and ability to produce accurate results quickly, are driving the expansion of the companion diagnostics market. It is now well accepted that medications can interact differently with different people as a result of advancements in genetic sequencing and genomics.

And the technique of giving "the correct drug, at the right time, at the right dose, for the right person" can be advanced with a greater understanding of a person's genetic traits or biomarkers.

In order to give focused therapeutics to the appropriate candidate, pharmaceutical and biopharmaceutical companies are continuously working to adopt patient-selection diagnostic frameworks in the early stages of drug development. And the same is anticipated to push forward the adoption of companion diagnostics to a considerable extent over the forecast period.

Customize this Report

Let us know your requirement to get
100% FREE customization

What are the Key Companion Diagnostics Market Dynamics?

With rapid technological advancement and increase in the incidence of chronic disease, the demand for companion diagnostics is likely to spike, where the major impact of companion diagnostic is likely to be on oncology therapy area. Presently, companion diagnostics global market is driven by the technological advancement in healthcare industry as well as increase in various treatment procedures.

Number of companion diagnostics can be given approval for a single drug as scientific knowledge advances with practical application of treatment.

On the flip side, cost related to the latest technology acts as a key barrier for the global companion diagnostics market growth.

Why is North America Anticipated to Hold a Monopoly over the Companion Diagnostics Market?

North America is the leading market for companion diagnostics with a share of 25.4% in 2022 on account of rapid technical inventions as well as the increasing prevalence of chronic diseases like cancer.

Additionally, companion diagnostics market trends and forecast are swayed expansion of research activities in this field employing companion diagnostic kits and the growing number of healthcare organisations working on genetic databases created to comprehend the human genome.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What is the Growth Outlook for the Companion Diagnostics Market in Europe?

The second-highest market is anticipated to be in Europe with a market share of companion diagnostics market share of 21.6% in 2022.

A substantial number of businesses are expected to participate as the regional sector expands, and research and development efforts to enhance personalized drug therapy for cancer patients are expected to increase, in turn impacting the regional market. Additionally, rising per capita income increases the desire for individualized care, further promoting consumer development.

How is the Start-Up Ecosystem in the Companion Diagnostics Market?

Numerous start-ups have been founded by many eminent personalities, leaving their mark in the companion diagnostics market, in turn auguring well for the companion diagnostics market future trends.

Example:

For the past 18 years, Ali Ardakani has played a crucial role in the founding and growth of numerous biotech businesses, pharmaceuticals, and medical devices, for which he has raised over $100 M USD in private and grant funding.

His most recent venture was the co-founding of the virtual biotech start-up Niiki Pharma Inc. in NYC, where he purchased two first-in-class oncology medications from Europe and expedited their development through UK CTA, US IND, and Phase 1 and 2 clinical trials in under 3 years.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

What is the Competition Landscape in the Companion Diagnostics Market?

The companion diagnostics market is fairly competitive, where players in the market primarily engage acquisitions, product releases, and collaborations as their primary business strategies.

A few of such recent developments in the companion diagnostics market are:

  • Therascreen PIK3CA RGQ PCR Kit was introduced by QIAGEN N.V. in PIQRAY (alpelisib) therapy in the US to expand its product line in the Companion Diagnostics Market.
  • Thermo Fisher Science Inc. and Agios Pharmaceuticals have partnered strategically to create a second companion oncology diagnostic tool.
  • AstraZeneca plc, Merck Group, and Myriad Genetics, Inc. (US) joined forces to find unmet medical needs in men with metastatic castration-resistant prostate cancer and to increase the company's patient access in the market.

Key players:

  • ARUP Laboratories
  • Roche Molecular Systems Inc.
  • Dako Inc.
  • Qiagen Ltd.
  • bioMérieux Inc.
  • Ventana Medical Systems Inc.
  • Abbott Molecular Inc.
  • Myriad Genetics Inc.
  • Biogenex Laboratories, Inc.
  • Thermo Fisher Scientific Inc.
  • Leica Biosystems Nussloch GmbH
  • Others

Report Scope

Report Attribute

Details

Growth Rate

CAGR of 7.1% from 2022 to 2032

Base Year for Estimation

2021

Historical Data

2014-2020

Forecast Period

2022-2032

Quantitative Units

Revenue in USD Million, Volume in Kilotons and CAGR from 2022-2032

Report Coverage

Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis

Segments Covered

  • Application
  • Technology
  • Region

Regions Covered

  • North America
  • Latin America
  • Asia Pacific
  • The Middle East and Africa
  • Europe

Key Countries Profiled

  • U.S
  • Canada
  • Brazil
  • Argentina
  • Germany
  • U.K
  • France
  • Spain
  • Italy
  • Nordics
  • BENELUX
  • Australia & New Zealand
  • China
  • India
  • ASEAN
  • GCC
  • South Africa

Key Companies Profiled

  • ARUP Laboratories
  • Roche Molecular Systems Inc.
  • Dako Inc.
  • Qiagen Ltd.
  • bioMérieux Inc.
  • Ventana Medical Systems Inc.
  • Abbott Molecular Inc.
  • Myriad Genetics Inc.
  • Biogenex Laboratories, Inc.
  • Thermo Fisher Scientific Inc.
  • Leica Biosystems Nussloch GmbH
  • Others

Customization

Available Upon Request

Key Segments Profiled in the Companion Diagnostics Market Survey

By Application:

  • Colorectal Cancer
  • Breast Cancer
  • Lung Cancer
  • Melanoma
  • Urology
  • Gastric Cancer

By Technology:

  • Immunohistochemistry
  • Molecular Diagnostics
  • In-situ Hybridization
  • FISH
  • CISH
  • Real Time PCR
  • Gene Sequencing

By Region:

  • North America
  • Latin America
  • Asia Pacific
  • The Middle East and Africa
  • Europe

Frequently Asked Questions

The global companion diagnostics market is likely to advance at 7.1% CAGR (2022-2032).

North America is projected to lead the companion diagnostics market with a share of 25.4% in 2022.

The companion diagnostics market is anticipated to account for US$ 5152.064939 million by 2032.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Companion Diagnostics Market Analysis 2017-2021 and Forecast, 2022-2032

    4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021

    4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Companion Diagnostics Market Analysis 2017-2021 and Forecast 2022-2032, By Application

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Mn) Analysis By Application, 2017-2021

    5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Application, 2022-2032

        5.3.1. Colorectal Cancer

        5.3.2. Breast Cancer

        5.3.3. Lung Cancer

        5.3.4. Melanoma

        5.3.5. Urology

        5.3.6. Gastric Cancer

    5.4. Y-o-Y Growth Trend Analysis By Application, 2017-2021

    5.5. Absolute $ Opportunity Analysis By Application, 2022-2032

6. Global Companion Diagnostics Market Analysis 2017-2021 and Forecast 2022-2032, By Technology

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Mn) Analysis By Technology, 2017-2021

    6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Technology, 2022-2032

        6.3.1. Immunohistochemistry

        6.3.2. Molecular Diagnostics

        6.3.3. In-situ Hybridization

        6.3.4. FISH

        6.3.5. CISH

        6.3.6. Real Time PCR

        6.3.7. Gene Sequencing

    6.4. Y-o-Y Growth Trend Analysis By Technology, 2017-2021

    6.5. Absolute $ Opportunity Analysis By Technology, 2022-2032

7. Global Companion Diagnostics Market Analysis 2017-2021 and Forecast 2022-2032, By Region

    7.1. Introduction

    7.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021

    7.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032

        7.3.1. North America

        7.3.2. Latin America

        7.3.3. Europe

        7.3.4. South Asia

        7.3.5. East Asia

        7.3.6. Oceania

        7.3.7. MEA

    7.4. Market Attractiveness Analysis By Region

8. North America Companion Diagnostics Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        8.2.1. By Country

            8.2.1.1. U.S.

            8.2.1.2. Canada

        8.2.2. By Application

        8.2.3. By Technology

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Application

        8.3.3. By Technology

    8.4. Key Takeaways

9. Latin America Companion Diagnostics Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        9.2.1. By Country

            9.2.1.1. Brazil

            9.2.1.2. Mexico

            9.2.1.3. Rest of Latin America

        9.2.2. By Application

        9.2.3. By Technology

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Application

        9.3.3. By Technology

    9.4. Key Takeaways

10. Europe Companion Diagnostics Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        10.2.1. By Country

            10.2.1.1. Germany

            10.2.1.2. U.K.

            10.2.1.3. France

            10.2.1.4. Spain

            10.2.1.5. Italy

            10.2.1.6. Rest of Europe

        10.2.2. By Application

        10.2.3. By Technology

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Application

        10.3.3. By Technology

    10.4. Key Takeaways

11. South Asia Companion Diagnostics Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        11.2.1. By Country

            11.2.1.1. India

            11.2.1.2. Malaysia

            11.2.1.3. Singapore

            11.2.1.4. Thailand

            11.2.1.5. Rest of South Asia

        11.2.2. By Application

        11.2.3. By Technology

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Application

        11.3.3. By Technology

    11.4. Key Takeaways

12. East Asia Companion Diagnostics Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        12.2.1. By Country

            12.2.1.1. China

            12.2.1.2. Japan

            12.2.1.3. South Korea

        12.2.2. By Application

        12.2.3. By Technology

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Application

        12.3.3. By Technology

    12.4. Key Takeaways

13. Oceania Companion Diagnostics Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        13.2.1. By Country

            13.2.1.1. Australia

            13.2.1.2. New Zealand

        13.2.2. By Application

        13.2.3. By Technology

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Application

        13.3.3. By Technology

    13.4. Key Takeaways

14. MEA Companion Diagnostics Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        14.2.1. By Country

            14.2.1.1. GCC Countries

            14.2.1.2. South Africa

            14.2.1.3. Israel

            14.2.1.4. Rest of MEA

        14.2.2. By Application

        14.2.3. By Technology

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Application

        14.3.3. By Technology

    14.4. Key Takeaways

15. Key Countries Companion Diagnostics Market Analysis

    15.1. U.S.

        15.1.1. Pricing Analysis

        15.1.2. Market Share Analysis, 2021

            15.1.2.1. By Application

            15.1.2.2. By Technology

    15.2. Canada

        15.2.1. Pricing Analysis

        15.2.2. Market Share Analysis, 2021

            15.2.2.1. By Application

            15.2.2.2. By Technology

    15.3. Brazil

        15.3.1. Pricing Analysis

        15.3.2. Market Share Analysis, 2021

            15.3.2.1. By Application

            15.3.2.2. By Technology

    15.4. Mexico

        15.4.1. Pricing Analysis

        15.4.2. Market Share Analysis, 2021

            15.4.2.1. By Application

            15.4.2.2. By Technology

    15.5. Germany

        15.5.1. Pricing Analysis

        15.5.2. Market Share Analysis, 2021

            15.5.2.1. By Application

            15.5.2.2. By Technology

    15.6. U.K.

        15.6.1. Pricing Analysis

        15.6.2. Market Share Analysis, 2021

            15.6.2.1. By Application

            15.6.2.2. By Technology

    15.7. France

        15.7.1. Pricing Analysis

        15.7.2. Market Share Analysis, 2021

            15.7.2.1. By Application

            15.7.2.2. By Technology

    15.8. Spain

        15.8.1. Pricing Analysis

        15.8.2. Market Share Analysis, 2021

            15.8.2.1. By Application

            15.8.2.2. By Technology

    15.9. Italy

        15.9.1. Pricing Analysis

        15.9.2. Market Share Analysis, 2021

            15.9.2.1. By Application

            15.9.2.2. By Technology

    15.10. India

        15.10.1. Pricing Analysis

        15.10.2. Market Share Analysis, 2021

            15.10.2.1. By Application

            15.10.2.2. By Technology

    15.11. Malaysia

        15.11.1. Pricing Analysis

        15.11.2. Market Share Analysis, 2021

            15.11.2.1. By Application

            15.11.2.2. By Technology

    15.12. Singapore

        15.12.1. Pricing Analysis

        15.12.2. Market Share Analysis, 2021

            15.12.2.1. By Application

            15.12.2.2. By Technology

    15.13. Thailand

        15.13.1. Pricing Analysis

        15.13.2. Market Share Analysis, 2021

            15.13.2.1. By Application

            15.13.2.2. By Technology

    15.14. China

        15.14.1. Pricing Analysis

        15.14.2. Market Share Analysis, 2021

            15.14.2.1. By Application

            15.14.2.2. By Technology

    15.15. Japan

        15.15.1. Pricing Analysis

        15.15.2. Market Share Analysis, 2021

            15.15.2.1. By Application

            15.15.2.2. By Technology

    15.16. South Korea

        15.16.1. Pricing Analysis

        15.16.2. Market Share Analysis, 2021

            15.16.2.1. By Application

            15.16.2.2. By Technology

    15.17. Australia

        15.17.1. Pricing Analysis

        15.17.2. Market Share Analysis, 2021

            15.17.2.1. By Application

            15.17.2.2. By Technology

    15.18. New Zealand

        15.18.1. Pricing Analysis

        15.18.2. Market Share Analysis, 2021

            15.18.2.1. By Application

            15.18.2.2. By Technology

    15.19. GCC Countries

        15.19.1. Pricing Analysis

        15.19.2. Market Share Analysis, 2021

            15.19.2.1. By Application

            15.19.2.2. By Technology

    15.20. South Africa

        15.20.1. Pricing Analysis

        15.20.2. Market Share Analysis, 2021

            15.20.2.1. By Application

            15.20.2.2. By Technology

    15.21. Israel

        15.21.1. Pricing Analysis

        15.21.2. Market Share Analysis, 2021

            15.21.2.1. By Application

            15.21.2.2. By Technology

16. Market Structure Analysis

    16.1. Competition Dashboard

    16.2. Competition Benchmarking

    16.3. Market Share Analysis of Top Players

        16.3.1. By Regional

        16.3.2. By Application

        16.3.3. By Technology

17. Competition Analysis

    17.1. Competition Deep Dive

        17.1.1. ARUP Laboratories

            17.1.1.1. Overview

            17.1.1.2. Product Portfolio

            17.1.1.3. Profitability by Market Segments

            17.1.1.4. Sales Footprint

            17.1.1.5. Strategy Overview

                17.1.1.5.1. Marketing Strategy

        17.1.2. Dako Inc.

            17.1.2.1. Overview

            17.1.2.2. Product Portfolio

            17.1.2.3. Profitability by Market Segments

            17.1.2.4. Sales Footprint

            17.1.2.5. Strategy Overview

                17.1.2.5.1. Marketing Strategy

        17.1.3. Qiagen Ltd.

            17.1.3.1. Overview

            17.1.3.2. Product Portfolio

            17.1.3.3. Profitability by Market Segments

            17.1.3.4. Sales Footprint

            17.1.3.5. Strategy Overview

                17.1.3.5.1. Marketing Strategy

        17.1.4. bioMérieux Inc.

            17.1.4.1. Overview

            17.1.4.2. Product Portfolio

            17.1.4.3. Profitability by Market Segments

            17.1.4.4. Sales Footprint

            17.1.4.5. Strategy Overview

                17.1.4.5.1. Marketing Strategy

        17.1.5. Ventana Medical Systems Inc.

            17.1.5.1. Overview

            17.1.5.2. Product Portfolio

            17.1.5.3. Profitability by Market Segments

            17.1.5.4. Sales Footprint

            17.1.5.5. Strategy Overview

                17.1.5.5.1. Marketing Strategy

        17.1.6. Abbott Molecular Inc.

            17.1.6.1. Overview

            17.1.6.2. Product Portfolio

            17.1.6.3. Profitability by Market Segments

            17.1.6.4. Sales Footprint

            17.1.6.5. Strategy Overview

                17.1.6.5.1. Marketing Strategy

        17.1.7. Myriad Genetics Inc.

            17.1.7.1. Overview

            17.1.7.2. Product Portfolio

            17.1.7.3. Profitability by Market Segments

            17.1.7.4. Sales Footprint

            17.1.7.5. Strategy Overview

                17.1.7.5.1. Marketing Strategy

        17.1.8. Biogenex Laboratories, Inc.

            17.1.8.1. Overview

            17.1.8.2. Product Portfolio

            17.1.8.3. Profitability by Market Segments

            17.1.8.4. Sales Footprint

            17.1.8.5. Strategy Overview

                17.1.8.5.1. Marketing Strategy

        17.1.9. Thermo Fisher Scientific Inc.

            17.1.9.1. Overview

            17.1.9.2. Product Portfolio

            17.1.9.3. Profitability by Market Segments

            17.1.9.4. Sales Footprint

            17.1.9.5. Strategy Overview

                17.1.9.5.1. Marketing Strategy

        17.1.10. Leica Biosystems Nussloch GmbH

            17.1.10.1. Overview

            17.1.10.2. Product Portfolio

            17.1.10.3. Profitability by Market Segments

            17.1.10.4. Sales Footprint

            17.1.10.5. Strategy Overview

                17.1.10.5.1. Marketing Strategy

18. Assumptions & Acronyms Used

19. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Companion Diagnostics Market Value (US$ Mn) Forecast by Region, 2017-2032

Table 2: Global Companion Diagnostics Market Value (US$ Mn) Forecast by Application, 2017-2032

Table 3: Global Companion Diagnostics Market Value (US$ Mn) Forecast by Technology, 2017-2032

Table 4: North America Companion Diagnostics Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 5: North America Companion Diagnostics Market Value (US$ Mn) Forecast by Application, 2017-2032

Table 6: North America Companion Diagnostics Market Value (US$ Mn) Forecast by Technology, 2017-2032

Table 7: Latin America Companion Diagnostics Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 8: Latin America Companion Diagnostics Market Value (US$ Mn) Forecast by Application, 2017-2032

Table 9: Latin America Companion Diagnostics Market Value (US$ Mn) Forecast by Technology, 2017-2032

Table 10: Europe Companion Diagnostics Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 11: Europe Companion Diagnostics Market Value (US$ Mn) Forecast by Application, 2017-2032

Table 12: Europe Companion Diagnostics Market Value (US$ Mn) Forecast by Technology, 2017-2032

Table 13: South Asia Companion Diagnostics Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 14: South Asia Companion Diagnostics Market Value (US$ Mn) Forecast by Application, 2017-2032

Table 15: South Asia Companion Diagnostics Market Value (US$ Mn) Forecast by Technology, 2017-2032

Table 16: East Asia Companion Diagnostics Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 17: East Asia Companion Diagnostics Market Value (US$ Mn) Forecast by Application, 2017-2032

Table 18: East Asia Companion Diagnostics Market Value (US$ Mn) Forecast by Technology, 2017-2032

Table 19: Oceania Companion Diagnostics Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 20: Oceania Companion Diagnostics Market Value (US$ Mn) Forecast by Application, 2017-2032

Table 21: Oceania Companion Diagnostics Market Value (US$ Mn) Forecast by Technology, 2017-2032

Table 22: MEA Companion Diagnostics Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 23: MEA Companion Diagnostics Market Value (US$ Mn) Forecast by Application, 2017-2032

Table 24: MEA Companion Diagnostics Market Value (US$ Mn) Forecast by Technology, 2017-2032

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: Global Companion Diagnostics Market Value (US$ Mn) by Application, 2022-2032

Figure 2: Global Companion Diagnostics Market Value (US$ Mn) by Technology, 2022-2032

Figure 3: Global Companion Diagnostics Market Value (US$ Mn) by Region, 2022-2032

Figure 4: Global Companion Diagnostics Market Value (US$ Mn) Analysis by Region, 2017-2032

Figure 5: Global Companion Diagnostics Market Value Share (%) and BPS Analysis by Region, 2022-2032

Figure 6: Global Companion Diagnostics Market Y-o-Y Growth (%) Projections by Region, 2022-2032

Figure 7: Global Companion Diagnostics Market Value (US$ Mn) Analysis by Application, 2017-2032

Figure 8: Global Companion Diagnostics Market Value Share (%) and BPS Analysis by Application, 2022-2032

Figure 9: Global Companion Diagnostics Market Y-o-Y Growth (%) Projections by Application, 2022-2032

Figure 10: Global Companion Diagnostics Market Value (US$ Mn) Analysis by Technology, 2017-2032

Figure 11: Global Companion Diagnostics Market Value Share (%) and BPS Analysis by Technology, 2022-2032

Figure 12: Global Companion Diagnostics Market Y-o-Y Growth (%) Projections by Technology, 2022-2032

Figure 13: Global Companion Diagnostics Market Attractiveness by Application, 2022-2032

Figure 14: Global Companion Diagnostics Market Attractiveness by Technology, 2022-2032

Figure 15: Global Companion Diagnostics Market Attractiveness by Region, 2022-2032

Figure 16: North America Companion Diagnostics Market Value (US$ Mn) by Application, 2022-2032

Figure 17: North America Companion Diagnostics Market Value (US$ Mn) by Technology, 2022-2032

Figure 18: North America Companion Diagnostics Market Value (US$ Mn) by Country, 2022-2032

Figure 19: North America Companion Diagnostics Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 20: North America Companion Diagnostics Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 21: North America Companion Diagnostics Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 22: North America Companion Diagnostics Market Value (US$ Mn) Analysis by Application, 2017-2032

Figure 23: North America Companion Diagnostics Market Value Share (%) and BPS Analysis by Application, 2022-2032

Figure 24: North America Companion Diagnostics Market Y-o-Y Growth (%) Projections by Application, 2022-2032

Figure 25: North America Companion Diagnostics Market Value (US$ Mn) Analysis by Technology, 2017-2032

Figure 26: North America Companion Diagnostics Market Value Share (%) and BPS Analysis by Technology, 2022-2032

Figure 27: North America Companion Diagnostics Market Y-o-Y Growth (%) Projections by Technology, 2022-2032

Figure 28: North America Companion Diagnostics Market Attractiveness by Application, 2022-2032

Figure 29: North America Companion Diagnostics Market Attractiveness by Technology, 2022-2032

Figure 30: North America Companion Diagnostics Market Attractiveness by Country, 2022-2032

Figure 31: Latin America Companion Diagnostics Market Value (US$ Mn) by Application, 2022-2032

Figure 32: Latin America Companion Diagnostics Market Value (US$ Mn) by Technology, 2022-2032

Figure 33: Latin America Companion Diagnostics Market Value (US$ Mn) by Country, 2022-2032

Figure 34: Latin America Companion Diagnostics Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 35: Latin America Companion Diagnostics Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 36: Latin America Companion Diagnostics Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 37: Latin America Companion Diagnostics Market Value (US$ Mn) Analysis by Application, 2017-2032

Figure 38: Latin America Companion Diagnostics Market Value Share (%) and BPS Analysis by Application, 2022-2032

Figure 39: Latin America Companion Diagnostics Market Y-o-Y Growth (%) Projections by Application, 2022-2032

Figure 40: Latin America Companion Diagnostics Market Value (US$ Mn) Analysis by Technology, 2017-2032

Figure 41: Latin America Companion Diagnostics Market Value Share (%) and BPS Analysis by Technology, 2022-2032

Figure 42: Latin America Companion Diagnostics Market Y-o-Y Growth (%) Projections by Technology, 2022-2032

Figure 43: Latin America Companion Diagnostics Market Attractiveness by Application, 2022-2032

Figure 44: Latin America Companion Diagnostics Market Attractiveness by Technology, 2022-2032

Figure 45: Latin America Companion Diagnostics Market Attractiveness by Country, 2022-2032

Figure 46: Europe Companion Diagnostics Market Value (US$ Mn) by Application, 2022-2032

Figure 47: Europe Companion Diagnostics Market Value (US$ Mn) by Technology, 2022-2032

Figure 48: Europe Companion Diagnostics Market Value (US$ Mn) by Country, 2022-2032

Figure 49: Europe Companion Diagnostics Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 50: Europe Companion Diagnostics Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 51: Europe Companion Diagnostics Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 52: Europe Companion Diagnostics Market Value (US$ Mn) Analysis by Application, 2017-2032

Figure 53: Europe Companion Diagnostics Market Value Share (%) and BPS Analysis by Application, 2022-2032

Figure 54: Europe Companion Diagnostics Market Y-o-Y Growth (%) Projections by Application, 2022-2032

Figure 55: Europe Companion Diagnostics Market Value (US$ Mn) Analysis by Technology, 2017-2032

Figure 56: Europe Companion Diagnostics Market Value Share (%) and BPS Analysis by Technology, 2022-2032

Figure 57: Europe Companion Diagnostics Market Y-o-Y Growth (%) Projections by Technology, 2022-2032

Figure 58: Europe Companion Diagnostics Market Attractiveness by Application, 2022-2032

Figure 59: Europe Companion Diagnostics Market Attractiveness by Technology, 2022-2032

Figure 60: Europe Companion Diagnostics Market Attractiveness by Country, 2022-2032

Figure 61: South Asia Companion Diagnostics Market Value (US$ Mn) by Application, 2022-2032

Figure 62: South Asia Companion Diagnostics Market Value (US$ Mn) by Technology, 2022-2032

Figure 63: South Asia Companion Diagnostics Market Value (US$ Mn) by Country, 2022-2032

Figure 64: South Asia Companion Diagnostics Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 65: South Asia Companion Diagnostics Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 66: South Asia Companion Diagnostics Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 67: South Asia Companion Diagnostics Market Value (US$ Mn) Analysis by Application, 2017-2032

Figure 68: South Asia Companion Diagnostics Market Value Share (%) and BPS Analysis by Application, 2022-2032

Figure 69: South Asia Companion Diagnostics Market Y-o-Y Growth (%) Projections by Application, 2022-2032

Figure 70: South Asia Companion Diagnostics Market Value (US$ Mn) Analysis by Technology, 2017-2032

Figure 71: South Asia Companion Diagnostics Market Value Share (%) and BPS Analysis by Technology, 2022-2032

Figure 72: South Asia Companion Diagnostics Market Y-o-Y Growth (%) Projections by Technology, 2022-2032

Figure 73: South Asia Companion Diagnostics Market Attractiveness by Application, 2022-2032

Figure 74: South Asia Companion Diagnostics Market Attractiveness by Technology, 2022-2032

Figure 75: South Asia Companion Diagnostics Market Attractiveness by Country, 2022-2032

Figure 76: East Asia Companion Diagnostics Market Value (US$ Mn) by Application, 2022-2032

Figure 77: East Asia Companion Diagnostics Market Value (US$ Mn) by Technology, 2022-2032

Figure 78: East Asia Companion Diagnostics Market Value (US$ Mn) by Country, 2022-2032

Figure 79: East Asia Companion Diagnostics Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 80: East Asia Companion Diagnostics Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 81: East Asia Companion Diagnostics Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 82: East Asia Companion Diagnostics Market Value (US$ Mn) Analysis by Application, 2017-2032

Figure 83: East Asia Companion Diagnostics Market Value Share (%) and BPS Analysis by Application, 2022-2032

Figure 84: East Asia Companion Diagnostics Market Y-o-Y Growth (%) Projections by Application, 2022-2032

Figure 85: East Asia Companion Diagnostics Market Value (US$ Mn) Analysis by Technology, 2017-2032

Figure 86: East Asia Companion Diagnostics Market Value Share (%) and BPS Analysis by Technology, 2022-2032

Figure 87: East Asia Companion Diagnostics Market Y-o-Y Growth (%) Projections by Technology, 2022-2032

Figure 88: East Asia Companion Diagnostics Market Attractiveness by Application, 2022-2032

Figure 89: East Asia Companion Diagnostics Market Attractiveness by Technology, 2022-2032

Figure 90: East Asia Companion Diagnostics Market Attractiveness by Country, 2022-2032

Figure 91: Oceania Companion Diagnostics Market Value (US$ Mn) by Application, 2022-2032

Figure 92: Oceania Companion Diagnostics Market Value (US$ Mn) by Technology, 2022-2032

Figure 93: Oceania Companion Diagnostics Market Value (US$ Mn) by Country, 2022-2032

Figure 94: Oceania Companion Diagnostics Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 95: Oceania Companion Diagnostics Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 96: Oceania Companion Diagnostics Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 97: Oceania Companion Diagnostics Market Value (US$ Mn) Analysis by Application, 2017-2032

Figure 98: Oceania Companion Diagnostics Market Value Share (%) and BPS Analysis by Application, 2022-2032

Figure 99: Oceania Companion Diagnostics Market Y-o-Y Growth (%) Projections by Application, 2022-2032

Figure 100: Oceania Companion Diagnostics Market Value (US$ Mn) Analysis by Technology, 2017-2032

Figure 101: Oceania Companion Diagnostics Market Value Share (%) and BPS Analysis by Technology, 2022-2032

Figure 102: Oceania Companion Diagnostics Market Y-o-Y Growth (%) Projections by Technology, 2022-2032

Figure 103: Oceania Companion Diagnostics Market Attractiveness by Application, 2022-2032

Figure 104: Oceania Companion Diagnostics Market Attractiveness by Technology, 2022-2032

Figure 105: Oceania Companion Diagnostics Market Attractiveness by Country, 2022-2032

Figure 106: MEA Companion Diagnostics Market Value (US$ Mn) by Application, 2022-2032

Figure 107: MEA Companion Diagnostics Market Value (US$ Mn) by Technology, 2022-2032

Figure 108: MEA Companion Diagnostics Market Value (US$ Mn) by Country, 2022-2032

Figure 109: MEA Companion Diagnostics Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 110: MEA Companion Diagnostics Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 111: MEA Companion Diagnostics Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 112: MEA Companion Diagnostics Market Value (US$ Mn) Analysis by Application, 2017-2032

Figure 113: MEA Companion Diagnostics Market Value Share (%) and BPS Analysis by Application, 2022-2032

Figure 114: MEA Companion Diagnostics Market Y-o-Y Growth (%) Projections by Application, 2022-2032

Figure 115: MEA Companion Diagnostics Market Value (US$ Mn) Analysis by Technology, 2017-2032

Figure 116: MEA Companion Diagnostics Market Value Share (%) and BPS Analysis by Technology, 2022-2032

Figure 117: MEA Companion Diagnostics Market Y-o-Y Growth (%) Projections by Technology, 2022-2032

Figure 118: MEA Companion Diagnostics Market Attractiveness by Application, 2022-2032

Figure 119: MEA Companion Diagnostics Market Attractiveness by Technology, 2022-2032

Figure 120: MEA Companion Diagnostics Market Attractiveness by Country, 2022-2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Poultry Diagnostics Market

Published : November 2020

Healthcare

Cancer Diagnostics Market

Published : March 2021

Healthcare

Tissue Diagnostics Market

Published : July 2020

Google translate

Companion Diagnostics Market